Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Ready-to-stir BLG ingredient offers patient-friendly solution for medical nutrition

Arla Foods Ingredients has launched a new ready-to-stir beta-lactoglobulin (BLG) solution to improve convenience and acceptability for patients needing protein-enriched medical nutrition.

Up to 50% of hospital patients suffer from malnutrition, which is associated with longer hospital stays, poor quality of life, increased mortality and higher healthcare costs.[1] Yet motivating patients with reduced appetites to consume sufficient protein through oral nutrition supplements is a challenge. Global surveys have shown that half fail to comply with their medical nutrition plans, with product taste and texture highlighted as opportunities for improvement.[2]

The medical nutrition market is dominated by highly standardised, milky ready-to-drink (RTD) and powder applications. These are typically formulated with neutral pH ingredients, which patients can find heavy and unrefreshing, while juice-style options are limited to RTDs. Patients and healthcare professionals alike are seeking a wider choice of flexible, convenient and appetising formats that can be easily mixed with everyday foods and drinks.[3]

Arla Foods Ingredients’ new Lacprodan® BLG-100 Acidic whey protein for ready-to-stir powder applications provides 10g of high-quality protein per 100ml serving. Due to its superior solubility, it offers excellent functionality for technically challenging, ready-to-stir powder applications that can be mixed with a spoon as well as shaken. Delivering a great, refreshing taste with no bitterness, low astringency and low viscosity without gelling, it dissolves in just 30 seconds in warm or cold applications without clumping.

Lacprodan® BLG-100 Acidic can be used in both nutritionally complete and incomplete applications, including refreshing juice-style and milky options. The flexible powder format enables easier dosage of the recommended daily medical nutrition prescription, with the final volume adjustable by varying the amount of water added.


[1] World Health Organization, Regional Office for Europe, “Disease-related malnutrition: a time for action”, 2023. https://www.who.int/europe/publications/i/item/WHO-EURO-2023-8931-48703-72392

[2] FMCG Gurus’ Medical Nutrition Insights database, Brazil, China, France, Germany, Indonesia, Italy, Japan, South Korea, Spain, UK, US, Vietnam, 2023; Qualitative study on medical nutrition, Lindberg International, China, Germany, UK, US, 2024

[3] FMCG Gurus’ Medical Nutrition Insights database, Brazil, China, France, Germany, Indonesia, Italy, Japan, South Korea, Spain, UK, US, Vietnam, 2023; Qualitative study on medical nutrition, Lindberg International, China, Germany, UK, US, 2024

Share the Post:

Related Posts

GELITA to showcase collagen solutions for active ageing – and unveil a BCP® innovation at Vitafoods Europe 2026, Booth 3B88

At Vitafoods Europe 2026, GELITA will highlight the growing role of collagen-based nutrition for ageing athletes and women’s health. Under its ‘Be Active!’ umbrella, the event’s official collagen sponsor will demonstrate how its Bioactive Collagen Peptides (BCP®) support targeted nutraceutical concepts for today’s performance-driven consumers. Another highlight at booth 3B88 will be the launch of a new ingredient within GELITA’s BCP® portfolio – CURADERM®, a newly developed collagen peptide solution for body barrier health and repair. The company will also be showcasing its versatile pharmaceutical-grade gelatin portfolio for advanced soft capsule performance.

Read More